Dr. Bob Baravarian is a nationally recognized foot and ankle surgeon known for his innovative treatment techniques, surgical skill, and patient-first approach.
With decades of experience treating complex foot and ankle conditions, Dr. Baravarian is trusted by athletes, professionals, and individuals seeking long-lasting relief.
Through his unique combination of advanced non-surgical therapies and minimally invasive surgical techniques, Dr. Baravarian has helped thousands of patients regain pain-free movement, and he accomplishes this with precision, compassion, and a strong dedication to pioneering advancements in patient care and treatments.
Dr. Baravarian has been a leading figure in advancing foot and ankle care in the United States, creating innovative protocols and treatment methods that have shaped modern foot and ankle care.
His clinical leadership and reputation for excellence have led to early access to breakthrough technologies, often years before they become widely available, ensuring his patients receive the most advanced and effective treatments.
Dr. Baravarian is currently the Chief of Podiatric Foot and Ankle Surgery at Providence Saint John’s Medical Center and has served as an Assistant Clinical Professor at the University of California, Los Angeles (UCLA) School of Medicine and Chief of Podiatric Surgery at UCLA Santa Monica Medical Center. He has participated in numerous clinical research studies across North America, improving the quality of care and treatment options for thousands of patients worldwide. Additionally, he led a podiatric fellowship training program, training many Southern Californian foot and ankle specialists.
He also regularly speaks at national and international medical conferences, delivers lectures on the latest foot and ankle techniques, and hosts physician training programs and fellowships. His published work includes hundreds of articles and case studies in esteemed medical journals.
OSSIOfiber® Center of Excellence
Reserved for surgeons with the highest level of experience of use with OSSIOfiber®, Centers of Excellence are highly trained on OSSIOfiber® technologies, have the highest patient volumes over time, and maintain use of OSSIOfiber® monthly.
1. Data on file at OSSIO2. Clinical study data on file at OSSIO3. Kaiser, P.B., Watkins, I., Riedel, M. D., Cronin, P., Briceno, J., Kron, J. Y. (2019). Implant Removal Matrix for the Foot and Ankle Orthopaedic Surgeon. Foot & Ankle Specialist, 12(1), 79-97. https://doi.org/10.1177/19386400187910154. Pre-clinical animal studies (in-bone implantation of OSSIOfiber® and PLDLA control in rabbit femurs). Data on File at OSSIO.5.Haddad, S. F., Helm, M. M., Meath, B., Adams, C., Packianathan, N., & Uhl, R. (2019). Exploring the Incidence, Implications, and Relevance of Metal Allergy to Orthopaedic Surgeons. Journal of the American Academy of Orthopaedic Surgeons. Global research & reviews, 3(4), e023. https://doi.org/10.5435/JAAOSGlobal-D-19-00023
